Now showing items 1190-1209 of 1277
| Title | Author(s) | Journal | Issue Date | Type |
|---|---|---|---|---|
| TropMed Central Antwerp: moving towards "access for all" | Didden, K. | ITGa.zet | 2009 | Article |
| Trypanosoma brucei gambiense spliced leader RNA is a more specific marker for cure of human African trypanosomiasis than T.b. gambiense DNA | Ilboudo, H.; Camara, O.; Ravel, S.; Bucheton, B.; Lejon, V.; Camara, M.; Kabore, J.; Jamonneau, V.; Deborggraeve, S. | Journal of Infectious Diseases | 2015 | Article |
| Trypanosoma brucei parasites occupy and functionally adapt to the adipose tissue in mice | Trindade, S.; Rijo-Ferreira, F.; Carvalho, T.; Pinto-Neves, D.; Guegan, F.; Aresta-Branco, F.; Bento, F.; Young, S. A.; Pinto, A.; Van Den Abbeele, J.; Ribeiro, R. M.; Dias, S.; Smith, T. K.; Figueiredo, L. M. | Cell Host and Microbe | 2016 | Article |
| Trypanosoma vivax GM6 antigen: a candidate antigen for diagnosis of African animal trypanosomosis in cattle | Pillay, D.; Izotte, J.; Fikru, R.; Büscher, P.; Mucache, H.; Neves, L.; Boulangé, A.; Seck, M. T.; Bouyer, J.; Napier, G. B.; Chevtzoff, C.; Coustou, V.; Baltz, T. | PLoS ONE | 2013 | Article-E |
| Trypanosome infection in dromedary camels in Eastern Ethiopia: prevalence, relative performance of diagnostic tools and host related risk factors | Fikru, R.; Andualem, Y.; Getachew, T.; Menten, J.; Hasker, E.; Merga, B.; Goddeeris, B. M.; Büscher, P. | Veterinary Parasitology | 2015 | Article |
| Trypanosomosis risk factors and impact assessment of a tsetse and trypanosomosis eradication campaign in Burkina Faso | Sow, A. | 2013 | Dissertation | |
| Tsetse fly tolerance to T. brucei infection: transcriptome analysis of trypanosome-associated changes in the tsetse fly salivary gland | Matetovici, I.; Caljon, G.; Van Den Abbeele, J. | BMC Genomics | 2016 | Article-E |
| Tsetse saliva proteins as biomarkers of vector exposure | Van Den Abbeele, J.; Caljon, G. | 2017 | Chapter | |
| Tsetse salivary gland proteins 1 and 2 are high affinity nucleic acid binding proteins with residual nuclease activity | Caljon, G.; De Ridder, K.; Stijlemans, B.; Coosemans, M.; Magez, S.; De Baetselier, P.; Van Den Abbeele, J. | PLoS ONE | 2012 | Article-E |
| Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda | Kirenga, B. J.; Worodria, W.; Massinga-Loembe, M.; Nalwoga, T.; Manabe, Y. C.; Kestens, L.; Colebunders, R.; Mayanja-Kizza, H. | International Journal of Tuberculosis and Lung Disease | 2013 | Article |
| Tuberculosis-associated immune reconstitution inflammatory syndrome: a manifestation of adaptive or innate immunity? [comment] | Goovaerts, O.; Kestens, L. | Lancet Infectious Diseases | 2015 | Article |
| Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014 | Diarra, B.; Goita, D.; Tounkara, S.; Sanogo, M.; Baya, B.; Togo, A. C.; Maiga, M.; Sarro, Y. S.; Kone, A.; Kone, B.; M'Baye, O.; Coulibaly, N.; Kassambara, H.; Cisse, A.; Belson, M.; Polis, M. A.; Otu, J.; Gehre, F.; Antonio, M.; Dao, S.; Siddiqui, S.; Murphy, R. L.; de Jong, B. C.; Diallo, S. | BMC Infectious Diseases | 2016 | Article-E |
| Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda | Ssengooba, W.; Lukoye, D.; Meehan, C. J.; Kateete, D. P.; Joloba, M. L.; de Jong, B. C.; Cobelens, F. G.; van Leth, F. | International Journal of Tuberculosis and Lung Disease | 2017 | Article |
| Tuberculosis treatment: one-shot approach or cascade of regimens? [letter] | Decroo, T.; de Jong, B. C.; Piubello, A.; Lynen, L.; Van Deun, A. | Lancet Respiratory Medicine | 2020 | Letter |
| Twenty years of global surveillance of antituberculosis-drug resistance | Zignol, M.; Dean, A. S.; Falzon, D.; van Gemert, W.; Wright, A.; Van Deun, A.; Portaels, F.; Laszlo, A.; Espinal, M. A.; Pablos-Mendez, A.; Bloom, A.; Aziz, M. A.; Weyer, K.; Jaramillo, E.; Nunn, P.; Floyd, K.; Raviglione, M. C. | New England Journal of Medicine | 2016 | Article |
| Twenty years of rifampicin resistance surveillance in Bangladesh: periodic vs. continuous monitoring | Van Deun, A.; Aung, K. J. M.; Hossain, M. A.; Salim, M. A. H.; Gumusboga, M.; de Jong, B. C.; Decroo, T. | International Journal of Tuberculosis and Lung Disease | 2018 | Article |
| Two distinct lineages of chikungunya virus cocirculated in Aruba during the 2014-2015 epidemic | Phadungsombat, J.; Tuekprakhon, A.; Cnops, L.; Michiels, J.; Van Den Berg, R.; Nakayama, E. E.; Shioda, T.; Ariën, K. K.; Huits, R. | Infection, Genetics and Evolution | 2019 | Article |
| Two distinct lineages of chikungunya virus cocirculated in Aruba during the 2014-2015 epidemic | Phadungsombat, J.; Tuekprakhon, A.; Cnops, L.; Michiels, J.; Van Den Berg, R.; Nakayama, E. E.; Shioda, T.; Ariën, K. K.; Huits, R. | Infection, Genetics and Evolution | 2020 | Article |
| Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines | Pollard, C.; Rejman, J.; De Haes, W.; Verrier, B.; Van Gulck, E.; Naessens, T.; De Smedt, S.; Bogaert, P.; Grooten, J.; Vanham, G.; De Koker, S. | Molecular Therapy | 2013 | Article |
| Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses | De Beuckelaer, A.; Pollard, C.; Van Lint, S.; Roose, K.; Van Hoecke, L.; Naessens, T.; Udhayakumar, V. K.; Smet, M.; Sanders, N.; Lienenklaus, S.; Saelens, X.; Weiss, S.; Vanham, G.; Grooten, J.; De Koker, S. | Molecular Therapy | 2016 | Article |
Now showing items 1190-1209 of 1277